Approvals/CIMA-AEMPS/XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Sanofi B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: d6c44ec002e1f509
Drug Cima Aemps Name: XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1221659001
Holder Company Name: Sanofi B.V.
Marketing Company Name: Sanofi Aventis S.A.
Holder Company Detail Path: /organization/sanofi-b-v
Authorization Date: 2022-07-29
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 20 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Sanofi B.V.
Company Detail Path: /organization/sanofi-b-v

OLIPUDASA ALFA

20 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 29, 2022

Approval ID

d6c44ec002e1f509

Type

Standard